Ten deprescribing articles you should know about: A guide for newcomers to the field.
Ten deprescribing articles you should know about: A guide for newcomers to the field.
复制标题
您应该了解的十篇处方文章：该领域新手指南。
DOI：
10.1111/bcpt.13877
复制
发表时间：
2023
影响因子：
3.1
通讯作者：
Lundby,Carina
中科院分区：
文献类型：
--
作者：
Thompson,Wade;Reeve,Emily;McDonald,EmilyG;Farrell,Barbara;Scott,Sion;Steinman,MichaelA;Morin,Lucas;Lundby,Carina
披露：本文的作者撰写并与本评论中提到的几项研究的作者合作。Reeve博士得到了NHMRC研究者补助金（GNT 1195460）和国家老龄化研究所赠款（R33-AG 057289和R 01-AG 070047 -01）的支持。她还收到版税共同撰写的一章关于取消在UpToDate和酬金从澳大利亚医院药剂师协会（领导讲习班取消）。锡永Scott与INVISIO Pharmaceuticals、Desitin Pharma和iEthico进行了研究合作，但在这些组织中没有经济利益。Michael A.斯坦曼是由美国国家老龄化研究所（R24 AG 064025，K24 AG 049057，P30 AG 044281）的赠款支持，并收到来自美国老年医学会和UpToDate的章节作者酬金。McDonald博士是MedSafer软件的创建者和所有者，该软件被MedSafer公司许可使用。MedSafer为取消处方提供电子决策支持。Farrell博士因撰写教科书章节而获得美国临床药学院的酬金，并作为科学咨询委员会成员获得美国开处方研究网络的酬金。汤普森博士获得了美国取消处方网络（美国国家老龄化研究所）的资助。
Disclosures: Authors on this article have authored and collaborated with authors of several of the studies mentioned in this commentary. Dr Reeve is supported by an NHMRC Investigator Grant (GNT1195460) and grants from the National Institute on Aging (R33-AG057289 and R01-AG070047-01). She also receives royalties for co-authoring a chapter on deprescribing in UpToDate and honorarium from the Society of Hospital Pharmacists of Australia (leading workshops on deprescribing). Sion Scott has/has had research collaborations with INVISIO Pharmaceuticals, Desitin Pharma and iEthico but has no financial interest in the organisations. Michael A. Steinman is supported by grants from the US National Institute on Aging (R24AG064025, K24AG049057, P30AG044281) and receives honoraria from the American Geriatrics Society and from UpToDate for chapter authorship. Dr. McDonald is the creator and owner of the software MedSafer, licensed for used by MedSafer Corp. MedSafer provides electronic decision support for deprescribing. Dr. Farrell has received honoraria from the American College of Clinical Pharmacy for a textbook chapter and from the United States Deprescribing Research Network as a Scientific Advisory Board Member. Dr. Thompson has received a grant from the US Deprescribing Network (US National Institute on Aging).